Remote blood pressure monitoring with pharmacist-led telehealth for people living with HIV
Official title: REMAP-BP-HIV: REmote Blood Pressure Monitoring and Pharmacist-Led Telehealth Program among People Living with HIV.
Funded at University of Alabama at Birmingham · NIH-11471223 · Data updated 2026-11-12
A plan to remotely track blood pressure and support HIV patients with pharmacist-led telehealth and reminders to bring BP under control.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | September 4, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $792,102 |
| NIH project number | 1R01HL189495-01 |
| Project ID | NIH-11471223 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who have uncontrolled blood pressure (BP ≥130/80 mmHg or on antihypertensive meds).
✕Less likely to help
Patients who do not have access to telehealth or who are not on antihypertensive therapy may receive less direct benefit.
What this research studies
People living with HIV often have high blood pressure that is not well controlled, contributing to heart disease. This program uses home BP monitoring, pharmacist-led telehealth visits, and automated reminders to help manage BP as part of HIV care. The study builds on a successful pilot by expanding to a larger, real-world setting in the Southern United States. It combines clinical care with implementation strategies to make BP control easier and more routine for PWH.
Why it matters
Potential benefit: If successful, patients could achieve better blood pressure control and reduce cardiovascular risk while staying engaged in HIV care.
How similar studies have gone: A prior pilot RCT showed high reach, fidelity, and improved BP control with the bundled approach.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Ghazi, Lama — University of Alabama at Birmingham
- Study coordinator: Ghazi, Lama
Related research
Other NIH-funded projects on the same topics.
-
Non-invasive, continuous blood pressure monitoring for prenatal maternal health
A wearable device from PyrAmes uses comfortable, non-invasive sensors and smart software to constantly monitor a pregnant person’s blood pressure and heart health so doctors can protect both mom and baby.
-
Smartphone app helps pregnant women in Ghana monitor blood pressure at home
A smartphone app is being customized for pregnant women in Ghana to support home blood pressure monitoring and improve safety during pregnancy.
-
Non-Invasive AI-Enhanced Neonatal Blood Pressure Monitoring in NICUs
A new AI-powered system uses the baby’s existing sensors to continuously track blood pressure in the NICU without invasive procedures, helping clinicians spot problems early.
-
Remote blood pressure monitoring with pharmacist-led telehealth after ED discharge
A new program helps adults with high blood pressure receive BP monitoring and medication support after leaving the emergency department, with pharmacists guiding telehealth visits and automated reminders.
-
Cuffless wireless ultrasound tattoo to monitor blood pressure
A wearable, skin-like ultrasound device will wirelessly measure and track blood pressure continuously in kids and patients, using a tiny chip and smart data signals.
-
Home blood pressure program adapted for rural Mississippi
A program helps adults in rural Mississippi manage high blood pressure using home monitoring and a smartphone-based virtual coach.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.